Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?
about
Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female.Sunitinib tolerance and efficacy in patients with metastatic renal cell carcinoma according to ethnic and geographic factors.Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients.
P2860
Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Sunitinib in metastatic renal ...... tly than the Western patients?
@en
Sunitinib in metastatic renal cell carcinoma
@nl
type
label
Sunitinib in metastatic renal ...... tly than the Western patients?
@en
Sunitinib in metastatic renal cell carcinoma
@nl
prefLabel
Sunitinib in metastatic renal ...... tly than the Western patients?
@en
Sunitinib in metastatic renal cell carcinoma
@nl
P2093
P2860
P1476
Sunitinib in metastatic renal ...... tly than the Western patients?
@en
P2093
Abdul Rashid Lone
Gull Mohammad Bhat
Mohmad Hussain Mir
Shiekh Aejaz Aziz
P2860
P304
P356
10.1007/S11255-016-1380-2
P577
2016-07-23T00:00:00Z